Element Capital Management’s Rein Therapeutics RNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-697
Closed -$38K 923
2018
Q3
$38K Sell
697
-762
-52% -$51.3K ﹤0.01% 871
2018
Q2
$158K Buy
+1,459
New +$165K ﹤0.01% 762

Other funds holding RNTX

Element Capital Management's RNTX Position: Q4 2018 in Review

Element Capital Management sold out of Rein Therapeutics (RNTX) in Q4 2018, closing a stake of 697 shares — an estimated $38K sold.

Element Capital Management first reported a position in RNTX in Q2 2018 and held it in 2 quarters. The position peaked at $158K in Q2 2018. 23 funds tracked by Wall St. Rank hold RNTX as of Q4 2018.

  • Element Capital Management reported no remaining Rein Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Element Capital Management sold 697 Rein Therapeutics shares in Q4 2018, an estimated $38K.
  • Element Capital Management first reported a position in Rein Therapeutics in Q2 2018 and held it in 2 quarters.
  • Element Capital Management's Rein Therapeutics position peaked at $158K in Q2 2018.
  • 23 funds tracked by Wall St. Rank held Rein Therapeutics as of Q4 2018.

Based on Element Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.